Systemic infection with Escherichia coli on postnatal day (P) 4 in rats results in significantly altered brain cytokine responses and behavioral changes in adulthood, but only in response to a subsequent immune challenge with lipopolysaccharide [LPS]. The basis for these changes may be long-term changes in glial cell function. We assessed glial and neural cell genesis in the hippocampus, parietal cortex (PAR), and prefrontal cortex (PFC), in neonates just after the infection, as well as in adulthood in response to LPS. E. coli increased the number of newborn microglia within the hippocampus and PAR compared to controls. The total number of microglia was also significantly increased in E. coli-treated pups, with a concomitant decrease in total proliferation. On P33, there were large decreases in numbers of cells coexpressing BrdU and NeuN in all brain regions of E. coli rats compared to controls. In adulthood, basal neurogenesis within the dentate gyrus (DG) did not differ between groups; however, in response to LPS, there was a decrease in neurogenesis in early-infected rats, but an increase in controls to the same challenge. There were also significantly more microglia in the adult DG of early-infected rats, although microglial proliferation in response to LPS was increased in controls. Taken together, we have provided evidence that systemic infection with E. coli early in life has significant, enduring consequences for brain development and subsequent adult function. These changes include marked alterations in glia, as well as influences on neurogenesis in brain regions important for cognition.
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Introduction
Microglia are the primary immunocompetent cells of the brain, with demonstrated roles in both protection and pathology. For instance, they appear to be neuroprotective following stroke, by producing trophic factors that aid in cellular repair (Lalancette-Hebert et al., 2007) . In contrast, chronic or exaggerated microglial activation is associated with multiple neuroinflammatory diseases, including Parkinson's, Alzheimer's, and Huntington's disease (Perry, 2004 ). Activated microglia produce many factors, including superoxide, nitric oxide, and cytokines, that may lead to neuronal damage or interfere with neuronal function directly (Block et al., 2007) . Microglial activation is also associated with multiple neurodevelopmental disorders with known or suspected immune etiologies, including autism, schizophrenia, and cerebral palsy, although the direction of causality in the majority of these disorders is unknown (Bilbo and Schwarz, in press; Meyer et al., 2005; Vargas et al., 2005) .
We have reported that systemic infection with Escherichia coli on postnatal day (P) 4 in rats is associated with marked hippocampal-dependent memory impairments in adulthood. However, these impairments are only observed if a second immune challenge (bacterial lipopolysaccharide [LPS] ) is administered in close proximity to learning in adulthood (Bilbo et al., 2005a,b) . The impairment is linked to exaggerated pro-inflammatory cytokine production to the LPS challenge, and decreased learning-induced brain-derivedneurotrophic factor (BDNF) expression within the hippocampus, a growth factor critical for memory consolidation (Bilbo et al., 2008 (Bilbo et al., , 2007 . Importantly, this low dose of LPS does not impair memory in control rats. Thus, infection during the neonatal period appears to act as a ''vulnerability" factor, by amplifying the adult rat's central cytokine response to the LPS challenge, which then impairs cognition.
We have hypothesized that the basis for this vulnerability may be long-term changes in glial cell function. Microglia are the primary cytokine producers within the brain, and are an excellent candidate for long-term changes, because they are long-lived and can become and remain activated chronically (Town et al., 2005) . There is increasing support for the concept of ''glial priming", in 
